pmc logo image
Logo of califmedJournal URL: tocrender.fcgi?issn=0093-0415&action=archive
Journal List > Calif Med > v.114(4); Apr 1971

Formats:
Calif Med. 1971 April; 114(4): 19–30.
PMCID: PMC1501857
Copyright notice
The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II.
C R Kleeman, S G Massry, and J W Coburn
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 19
19
icon of scanned page 20
20
icon of scanned page 21
21
icon of scanned page 22
22
icon of scanned page 23
23
icon of scanned page 24
24
icon of scanned page 25
25
icon of scanned page 26
26
icon of scanned page 27
27
icon of scanned page 28
28
icon of scanned page 29
29
icon of scanned page 30
30
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Bauer W, Albright F, Aub JC. A CASE OF OSTEITIS FIBROSA CYSTICA (OSTEOMALACIA?) WITH EVIDENCE OF HYPERACTIVITY OF THE PARA-THYROID BODIES. METABOLIC STUDY II. J Clin Invest. 1930 Feb;8(2):229–248. [PubMed]
  • Black WC, 3rd, Utley JR. The differential diagnosis of parathyroid adenoma and chief cell hyperplasia. Am J Clin Pathol. 1968 Jun;49(6):761–775. [PubMed]
  • Nathaniels EK, Nathaniels AM, Wang CA. Mediastinal parathyroid tumors: a clinical and pathological study of 84 cases. Ann Surg. 1970 Feb;171(2):165–170. [PubMed]
  • Munson PL, Tashjian AH, Jr, Levine L. Evidence for parathyroid hormone in nonparathyroid tumors associated with hypercalcemia. Cancer Res. 1965 Aug;25(7):1062–1067. [PubMed]
  • Sherwood LM, O'Riordan JL, Aurbach GD, Potts JT., Jr Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab. 1967 Jan;27(1):140–146. [PubMed]
  • Reiss E, Canterbury JM. Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N Engl J Med. 1969 Jun 19;280(25):1381–1385. [PubMed]
  • Lloyd HM. Primary hyperparathyroidism: an analysis of the role of the parathyroid tumor. Medicine (Baltimore). 1968 Jan;47(1):53–71. [PubMed]
  • Nichols G, Jr, Flanagan B. Normocalcemic hyperparathyroidism. Trans Assoc Am Physicians. 1967;80:314–322. [PubMed]
  • Yendt ER, Gagne RJ. Detection of primary hyperparathyroidism, with special reference to its occurrence in hypercalciuric females with "normal" or borderline serum calcium. Can Med Assoc J. 1968 Feb 17;98(7):331–336. [PubMed]
  • Reitz RE, Pollard JJ, Wang CA, Fleischli DJ, Cope O, Murray TM, Deftos LJ, Potts JT., Jr Localization of parathyroid adenomas by selective venous catheterization and radioimmunoassay. N Engl J Med. 1969 Aug 14;281(7):348–351. [PubMed]
  • Haas HG. Metabolic criteria for primary hyperparathyroidism. Helv Med Acta. 1966 Jun;33(2):91–107. [PubMed]
  • Popovtzer MM, Schainuck LI, Massry SG, Kleeman CR. Divalent ion excretion in chronic kidney disease: relation to degree of renal insufficiency. Clin Sci. 1970 Mar;38(3):297–307. [PubMed]
  • YAMAHIRO HS, REYNOLDS TB. Phosphate excretion in normal and hyperparathyroid subjects with controlled phosphate intake. Metabolism. 1962 Feb;11:213–225. [PubMed]
  • Yendt ER, Gagné RJ, Cohanim M. The effects of thiazides in idiopathic hypercalciuria. Am J Med Sci. 1966 Apr;251(4):449–460. [PubMed]
  • Parfitt AM. Chlorothiazide-induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N Engl J Med. 1969 Jul 10;281(2):55–59. [PubMed]
  • Koppel MH, Massry SG, Shinaberger JH, Hartenbower DL, Coburn JW. Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis. Ann Intern Med. 1970 Jun;72(6):895–901. [PubMed]
  • Bronsky D, Kiamko RT, Waldstein SS. Familial idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 1968 Jan;28(1):61–65. [PubMed]
  • Better OS, Garty J, Brautbar N, Barzilai D. Diminished functional parathyroid reserve following I-131 treatment for hyperthyroidism. Isr J Med Sci. 1969 May–Jun;5(3):419–422. [PubMed]
  • Lee JB, Tashjian AH, Jr, Streeto JM, Frantz AG. Familial pseudohypoparathyroidism. Role of parathyroid hormone and thyrocalcitonin. N Engl J Med. 1968 Nov 28;279(22):1179–1184. [PubMed]
  • Suh SM, Kooh SW, Chan AM, Fraser D, Tashjian AH., Jr Pseudohypoparathyroidism: no improvement following total thyroidectomy. J Clin Endocrinol Metab. 1969 Apr;29(4):429–439. [PubMed]
  • Tashjian AH, Jr, Frantz AG, Lee JB. Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1138–1142. [PubMed]
  • Gittes RF, Toverud SU, Cooper CW. Effects of hypercalcemia and hypocalcemia on the thyrocalcitonin content of rat thyroid glands. Endocrinology. 1968 Jan;82(1):83–90. [PubMed]
  • Ireland AW, Clubb JS, Neale FC, Posen S, Reeve TS. The calciferol requirements of patients with surgical hypoparathyroidism. Ann Intern Med. 1968 Jul;69(1):81–89. [PubMed]
  • DENT CE, FRIEDMAN M. A COMPARISON BETWEEN A.T. 10 AND PURE DIHYDROTACHYSTEROL IN CONTROLLING HYPOPARATHYROIDISM. Lancet. 1964 Jul 25;2(7352):164–169. [PubMed]
  • Harrison HE, Lifshitz F, Blizzard RM. Comparison between crystalline dihydrotachysterol and calciferol in patients requiring pharmacologic vitamin D therapy. N Engl J Med. 1967 Apr 20;276(16):894–900. [PubMed]
  • Kaye M, Chatterjee G, Cohen GF. Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis. Ann Intern Med. 1970 Aug;73(2):225–233. [PubMed]
  • Pak CY, DeLuca HF, Chavez de los Rios JM, Suda T, Ruskin B, Delea CS. Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol. Arch Intern Med. 1970 Aug;126(2):239–247. [PubMed]
  • Williams ED, Brown CL, Doniach I. Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J Clin Pathol. 1966 Mar;19(2):103–113. [PubMed]
  • Melvin KE, Tashjian AH., Jr The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid. Proc Natl Acad Sci U S A. 1968 Apr;59(4):1216–1222. [PubMed]
  • Johnston CI, Martin TJ, Riddell J. Medullary thyroid carcinoma: a functional peptidesecreting tumour. Australas Ann Med. 1970 Feb;19(1):50–53. [PubMed]
  • Marks SC., Jr The parafollicular cell of the thyroid gland as the source of an osteoblast-stimulating factor. Evidence from experimentally osteopetrotic mice. J Bone Joint Surg Am. 1969 Jul;51(5):875–890. [PubMed]
  • Marks SC, Jr, Walker DG. The role of the parafollicular cell of the thyroid gland in the pathogenesis of congenital osteopetrosis in mice. Am J Anat. 1969 Nov;126(3):299–313. [PubMed]
  • Kalu DN, Doyle FH, Pennock J, Foster GV. Parathyroid hormone and experimental osteosclerosis. Lancet. 1970 Jun 27;1(7661):1363–1366. [PubMed]
  • Melick RA, Baird CW. Changes in plasma calcium after injection of calcium in hypothyroid and hypoparathyroid women. J Clin Endocrinol Metab. 1967 Sep;27(9):1303–1308. [PubMed]
  • Martin TJ, Melick RA. The acute effects of porcine calcitonin in man. Australas Ann Med. 1969 Aug;18(3):258–263. [PubMed]
  • Milhaud G, Moukhtar MS, Bourichon J, Perault AM. Existence et activité de la thyrocalcitonine chez l'homme. C R Acad Sci Hebd Seances Acad Sci D. 1965 Nov 22;261(21):4513–4516. [PubMed]
  • Smith RN, Laljee HC. Thyrocalcitonin deficiency after treatment of thyroid disorders by surgery or radioiodine. Br Med J. 1967 Dec 9;4(5579):589–591. [PubMed]
Articles from California Medicine are provided here courtesy of
BMJ Group

PubMed articles by these authors